PIPRAFIN-TZ Injection contains Piperacillin 4000 mg and Tazobactam 500 mg, a well-established beta-lactam/beta-lactamase inhibitor combination. Piperacillin is a broad-spectrum penicillin antibiotic effective against gram-positive, gram-negative, and anaerobic bacteria, while Tazobactam inhibits beta-lactamase enzymes, protecting Piperacillin from degradation and extending its antibacterial coverage.

This injectable formulation is widely used in severe respiratory tract infections, intra-abdominal infections, urinary tract infections, skin and soft tissue infections, septicemia, and hospital-acquired infections, where rapid and reliable antimicrobial action is required.

Key Highlights:

• Contains Piperacillin 4000 mg + Tazobactam 500 mg

• Broad-spectrum activity against gram-positive, gram-negative, and anaerobic bacteria

• Effective against beta-lactamase producing organisms

• Commonly used in serious and hospital-acquired infections

• Suitable for empirical and targeted antibiotic therapy

• Injectable formulation for rapid systemic action

• For IV use only under strict medical supervision

Dosage, dilution, and duration should be determined by the physician based on infection severity, renal function, and clinical response.